Multivariate analysis suggested that relative lncRNA ANRIL expression level, TNM stage and lymph node metastasis were independent prognostic indicators for the overall survival of NSCLC patients (Table 2). This evidence concerns the gene CDKN2B-AS1 and metastatic malignant neoplasm in the lymph nodes.